Total Reports
27
Below-median volume
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for Turkey (other) (Turkey) in the FDA Center for Veterinary Medicine openFDA extract. Browse turkey breeds, reactions, and outcomes below.
By recorded gender -- every report on file for Turkey (other), no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Turkey (other) ranks #331 of 510 by total reports (27). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Turkey (other) has 27 reports now versus 27 in that prior snapshot: 0 the same number of (0.0%).
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Turkey (other) changesTotal Reports
27
Below-median volume
Deaths Reported
22
of 27 reports
Death-coded share of reports
81.5%
81.5% death-coded
Avg Age at Report
0.1 yr
4.0 kg avg weight
81.5% of 27 turkey (other) reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2011 | 14 | |
| 2012 | 4 | |
| 2013 | 3 | |
| 2014 | 3 | |
| 2015 | 1 | |
| 2016 | 1 | |
| 2024 | 1 | |
Signature read: Turkey (other)'s 81.5% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Turkey (other) sits at #335 of 510 by report volume among all breeds and #2 of 2 among turkey breeds, with 27 reports and 22 (81.5%) death-coded. Mean age at report: 0.1 years, average weight 4.0 kg (8.8 lbs).
Top reported signs: Death (18), Lateral recumbency (9), Recumbency (4). Most-referenced drug: Monensin Sodium (22 reports), followed by Narasin (2) and Ractopamine Hydrochloride (2).
Outcome coding on 36 status-recorded reports is dominated by Died (61.1%). Annual submissions ranged 1-2,024 across 7 years on file.
Two openFDA-derived peer sets for Turkey (other), both outside the Turkey family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds by reported average weight (4.0 kg here).
What to do with this turkey
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →